These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 27222255

  • 1. Downregulation of lncRNA CASC2 by microRNA-21 increases the proliferation and migration of renal cell carcinoma cells.
    Cao Y, Xu R, Xu X, Zhou Y, Cui L, He X.
    Mol Med Rep; 2016 Jul; 14(1):1019-25. PubMed ID: 27222255
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA‑21 contributes to renal cell carcinoma cell invasiveness and angiogenesis via the PDCD4/c‑Jun (AP‑1) signalling pathway.
    Fan B, Jin Y, Zhang H, Zhao R, Sun M, Sun M, Yuan X, Wang W, Wang X, Chen Z, Liu W, Yu N, Wang Q, Liu T, Li X.
    Int J Oncol; 2020 Jan; 56(1):178-192. PubMed ID: 31789394
    [Abstract] [Full Text] [Related]

  • 3. Long non-coding RNA CASC2 suppresses malignancy in human gliomas by miR-21.
    Wang P, Liu YH, Yao YL, Li Z, Li ZQ, Ma J, Xue YX.
    Cell Signal; 2015 Feb; 27(2):275-82. PubMed ID: 25446261
    [Abstract] [Full Text] [Related]

  • 4. Long non‑coding RNA CASC2 inhibits progression and predicts favorable prognosis in epithelial ovarian cancer.
    Xue Z, Zhu X, Teng Y.
    Mol Med Rep; 2018 Dec; 18(6):5173-5181. PubMed ID: 30320385
    [Abstract] [Full Text] [Related]

  • 5. Downregulation of the long noncoding RNA TUG1 inhibits the proliferation, migration, invasion and promotes apoptosis of renal cell carcinoma.
    Zhang M, Lu W, Huang Y, Shi J, Wu X, Zhang X, Jiang R, Cai Z, Wu S.
    J Mol Histol; 2016 Aug; 47(4):421-8. PubMed ID: 27323757
    [Abstract] [Full Text] [Related]

  • 6. lncRNA CASC2/miR‑18a‑5p axis regulates the malignant potential of nasopharyngeal carcinoma by targeting RBBP8.
    Miao WJ, Yuan DJ, Zhang GZ, Liu Q, Ma HM, Jin QQ.
    Oncol Rep; 2019 Mar; 41(3):1797-1806. PubMed ID: 30569153
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tumor suppressive microRNA‑138 contributes to cell migration and invasion through its targeting of vimentin in renal cell carcinoma.
    Yamasaki T, Seki N, Yamada Y, Yoshino H, Hidaka H, Chiyomaru T, Nohata N, Kinoshita T, Nakagawa M, Enokida H.
    Int J Oncol; 2012 Sep; 41(3):805-17. PubMed ID: 22766839
    [Abstract] [Full Text] [Related]

  • 10. microRNA-133b downregulation and inhibition of cell proliferation, migration and invasion by targeting matrix metallopeptidase-9 in renal cell carcinoma.
    Wu D, Pan H, Zhou Y, Zhou J, Fan Y, Qu P.
    Mol Med Rep; 2014 Jun; 9(6):2491-8. PubMed ID: 24714873
    [Abstract] [Full Text] [Related]

  • 11. lncRNA small nucleolar RNA host gene 12 promotes renal cell carcinoma progression by modulating the miR‑200c‑5p/collagen type XI α1 chain pathway.
    Xu C, Liang H, Zhou J, Wang Y, Liu S, Wang X, Su L, Kang X.
    Mol Med Rep; 2020 Nov; 22(5):3677-3686. PubMed ID: 32901847
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long noncoding RNA TUG1 promotes cell proliferation and migration of renal cell carcinoma via regulation of YAP.
    Liu S, Yang Y, Wang W, Pan X.
    J Cell Biochem; 2018 Dec; 119(12):9694-9706. PubMed ID: 30132963
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-20b-5p functions as a tumor suppressor in renal cell carcinoma by regulating cellular proliferation, migration and apoptosis.
    Li Y, Chen D, Jin L, Liu J, Su Z, Li Y, Gui Y, Lai Y.
    Mol Med Rep; 2016 Feb; 13(2):1895-901. PubMed ID: 26708577
    [Abstract] [Full Text] [Related]

  • 15. LncRNA CASC2 expression is down- regulated in papillary thyroid cancer and promotes cell invasion by affecting EMT pathway.
    Zhou T, Zhong M, Zhang S, Wang Z, Xie R, Xiong C, Lv Y, Chen W, Yu J.
    Cancer Biomark; 2018 Feb; 23(2):185-191. PubMed ID: 30175973
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. miR‑539 suppresses proliferation and induces apoptosis in renal cell carcinoma by targeting high mobility group A2.
    Ye ZH, Gui DW.
    Mol Med Rep; 2018 Apr; 17(4):5611-5618. PubMed ID: 29436648
    [Abstract] [Full Text] [Related]

  • 18. Long Non-Coding RNA DUXAP8 Enhances Renal Cell Carcinoma Progression via Downregulating miR-126.
    Huang T, Wang X, Yang X, Ji J, Wang Q, Yue X, Dong Z.
    Med Sci Monit; 2018 Oct 14; 24():7340-7347. PubMed ID: 30317248
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-22 is downregulated in clear cell renal cell carcinoma, and inhibits cell growth, migration and invasion by targeting PTEN.
    Fan W, Huang J, Xiao H, Liang Z.
    Mol Med Rep; 2016 Jun 14; 13(6):4800-6. PubMed ID: 27082730
    [Abstract] [Full Text] [Related]

  • 20. Tumor-suppressive microRNA-1291 directly regulates glucose transporter 1 in renal cell carcinoma.
    Yamasaki T, Seki N, Yoshino H, Itesako T, Yamada Y, Tatarano S, Hidaka H, Yonezawa T, Nakagawa M, Enokida H.
    Cancer Sci; 2013 Nov 14; 104(11):1411-9. PubMed ID: 23889809
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.